-Effect of cortistatin in serum cholesterol and glucose levels and in body weight and food intake. ApoE -/-mice fed a high-fat diet during 16 weeks were treated with PBS (control) or cortistatin (CST) three times per week starting one week after initiation of diet. Levels of cholesterol (32 mice/group) and glucose (12 mice/group) were determined in blood collected from tail vein at different time points. Mean of daily food intake was determined for the entire period (16 weeks, n=18 mice/group) and body weight (n=18 mice/group) was determined at different time points.
Time ( After washing, we determined the number of THP1 cells that remained bound to endothelial cells. Cell binding was expressed relative to untreated oxLDL-activated HUVECs. n=4, in duplicates. *p<0.05, **p<0.01 vs oxLDLactivated cells. B. Gene expression of adhesion molecules was determined by quantitative real-time PCR in the RNA samples isolated from HUVEC monolayers activated with oxLDL in the absence or presence of 10 nM cortistatin for 24 hours. n=4, in duplicates. **p<0.01 vs oxLDL-activated cells. C. Th1 cells differentiated in the absence (untreated Th1, black columns) or presence of cortistatin (CST-treated Th1, white columns) were assayed for binding to P-selectin and E-selectin chimeras. D. Migration capacity against medium (none) or a chemotactic stimuli (MCP-1) of peritoneal macrophages isolated from PBS-treated (control) or cortistatin-treated apoE -/-mice fed a high-fat diet for 16 weeks. n=6 mice/group. E. Migration capacity against MCP-1 of peritoneal macrophages isolated from apoE -/-mice fed a high-fat diet for 16 weeks and treated in vitro with medium or cortistatin (100 nM). n=3 experiments, in duplicates.
